Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Greenberg

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Cancer Research|September 15, 1996
Metastatic prostate cancer in a transgenic mouseJ R Gingrich, R J Barrios, R A Morton, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1994
The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic miceN M Greenberg, F J DeMayo, P C Sheppard, et al.
The Journal of Urology|September 29, 1998
Longitudinal cohort analysis of lethal prostate cancer progression in transgenic miceC X Hsu, B D Ross, C E Chrisp, et al.
The Prostate|July 3, 1998
Workgroup 3: transgenic and reconstitution models of prostate cancerJ E Green, N M Greenberg, C L Ashendel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 1995
Prostate cancer in a transgenic mouseN M Greenberg, F DeMayo, M J Finegold, et al.
Carcinogenesis|July 27, 2000
Genomic instability-based transgenic models of prostate cancerC Voelkel-Johnson, D J Voeks, N M Greenberg, et al.
Urologic Oncology|January 13, 2011
Recent advances in the development of animal and cell culture models for prostate cancer research A minireviewM C Bosland, L W Chung, N M Greenberg, et al.
Molecular Endocrinology (Baltimore, Md.)|January 6, 2001
Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation functionG Buchanan, M Yang, J M Harris, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancer Research|September 15, 1996
Metastatic prostate cancer in a transgenic mouseJ R Gingrich, R J Barrios, R A Morton, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1994
The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic miceN M Greenberg, F J DeMayo, P C Sheppard, et al.
The Journal of Urology|September 29, 1998
Longitudinal cohort analysis of lethal prostate cancer progression in transgenic miceC X Hsu, B D Ross, C E Chrisp, et al.
The Prostate|July 3, 1998
Workgroup 3: transgenic and reconstitution models of prostate cancerJ E Green, N M Greenberg, C L Ashendel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 1995
Prostate cancer in a transgenic mouseN M Greenberg, F DeMayo, M J Finegold, et al.
Carcinogenesis|July 27, 2000
Genomic instability-based transgenic models of prostate cancerC Voelkel-Johnson, D J Voeks, N M Greenberg, et al.
Urologic Oncology|January 13, 2011
Recent advances in the development of animal and cell culture models for prostate cancer research A minireviewM C Bosland, L W Chung, N M Greenberg, et al.
Molecular Endocrinology (Baltimore, Md.)|January 6, 2001
Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation functionG Buchanan, M Yang, J M Harris, et al.
Pageof 5